Fig. 1: Survival curves of all pediatric AML patients with and without NPM1 mutations, and according to the combined NPM1 and FLT3/ITD status. | Blood Cancer Journal

Fig. 1: Survival curves of all pediatric AML patients with and without NPM1 mutations, and according to the combined NPM1 and FLT3/ITD status.

From: Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia

Fig. 1

a Probability of EFS for patients with and without NPM1 mutations. b Probability of OS for patients with and without NPM1 mutations. c Probability of EFS for patients according to the combined NPM1 and FLT3/ITD status. d Probability of OS for patients according to the combined NPM1 and FLT3/ITD status.

Back to article page